NASDAQ:SBFM

Sunshine Biopharma (SBFM) Stock Forecast, Price & News

$0.61

+0.01 (+1.67%)

(As of 05/31/2023 ET)

Compare

Today's Range: $0.59
▼
$0.61
50-Day Range: $0.50
▼
$0.90
52-Week Range: $0.45
▼
$1.85

Volume: 87,674 shs
Average Volume: 924,058 shs
Market Capitalization: $15.00 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Sunshine Biopharma (NASDAQ:SBFM) Stock

Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. The firm's product include treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in Pointe-Claire, Canada.

Receive SBFM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sunshine Biopharma and its competitors with MarketBeat's FREE daily newsletter.

SBFM Stock News Headlines

May 16, 2023 | finanznachrichten.de

Aegis Capital Corp. Acted as Exclusive Placement Agent on a $5.0 Million Private Placement Priced At-the-Market for Sunshine Biopharma, Inc.

May 16, 2023 | finance.yahoo.com

Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-Market

June 1, 2023 | Behind the Markets (Ad)

"Unknown laser company making HUGE profit from Russia-Ukraine War"

On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>

May 16, 2023 | finance.yahoo.com

Aegis Capital Corp. Acted as Exclusive Placement Agent on a $5.0 Million Private Placement Priced At-the-Market for Sunshine Biopharma, Inc. (NASDAQ:SBFM)

May 12, 2023 | msn.com

Sunshine Biopharma to sell 5.95M units at $0.84 in private placement

May 12, 2023 | marketwatch.com

Sunshine Biopharma Shares Slide 22% Premarket on Private Placement >SBFM

May 12, 2023 | investorplace.com

SBFM Stock Alert: Why Sunshine Biopharma Is Down 28% Today

May 12, 2023 | finance.yahoo.com

Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market

June 1, 2023 | Behind the Markets (Ad)

"Unknown laser company making HUGE profit from Russia-Ukraine War"

May 11, 2023 | investorplace.com

SBFM Stock Alert: Why Sunshine Biopharma Is Up 80% Today

May 11, 2023 | technews.tmcnet.com

Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%

May 11, 2023 | finance.yahoo.com

Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%

April 25, 2023 | americanbankingnews.com

Sunshine Biopharma (SBFM) vs. The Competition Financial Review

April 16, 2023 | americanbankingnews.com

Sunshine Biopharma (SBFM) and The Competition Financial Contrast

April 15, 2023 | americanbankingnews.com

Analyzing Sunshine Biopharma (SBFM) & Its Rivals

April 14, 2023 | americanbankingnews.com

Reviewing Sunshine Biopharma (SBFM) and Its Rivals

April 12, 2023 | americanbankingnews.com

Sunshine Biopharma (NASDAQ:SBFM) and Immune Therapeutics (OTCMKTS:IMUN) Financial Analysis

April 5, 2023 | finance.yahoo.com

Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results and Provides Corporate Update

March 29, 2023 | cbsnews.com

First Alert Forecast: Sunshine returns Tuesday

February 28, 2023 | finanznachrichten.de

Financialnewsmedia.com: Coronavirus Vaccine Market To Surpass $95 Billion By 2028

February 10, 2023 | finance.yahoo.com

Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer Compound

January 19, 2023 | finance.yahoo.com

Sunshine Biopharma Announces Share Repurchase Program

December 20, 2022 | finanznachrichten.de

Sunshine Biopharma Inc.: Sunshine Biopharma's Annual Letter to Shareholders

December 20, 2022 | finance.yahoo.com

Sunshine Biopharma’s Annual Letter to Shareholders

December 12, 2022 | benzinga.com

Insider Buying: Sunshine Biopharma Inc. (NASDAQ: SBFM) Chief Financial Officer Purchases Shares

November 24, 2022 | uk.finance.yahoo.com

NASDAQ: SBFM

November 24, 2022 | finance.yahoo.com

NASDAQ: SBFM 👥 Enters Into A Collaboration Agreement For Its K1.1 Anticancer mRNA Project! 🔬

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive SBFM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sunshine Biopharma and its competitors with MarketBeat's FREE daily newsletter.

SBFM Company Calendar

Today: 5/31/2023
Next Earnings (Estimated): 8/02/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:SBFM
CUSIP: N/A
CIK: 1402328
Web: www.sunshinebiopharma.com
Phone: (514) 426-6161
Fax: N/A
Employees: 3
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($1.69)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-26,740,000.00
Net Margins: -298.45%
Pretax Margin: -295.39%
Return on Equity: -88.26%
Return on Assets: -78.25%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 3.61
Quick Ratio: 3.08

Sales & Book Value

Annual Sales: $4.35 million
Price / Sales: 3.45
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.79 per share
Price / Book: 0.77

Miscellaneous

Outstanding Shares: 24,590,000
Free Float: 23,361,000
Market Cap: $15.00 million
Optionable: Not Optionable
Beta: 2.08

Key Executives

Steve N. Slilaty
Chairman, President & Chief Executive Officer

Abderrazzak Merzouki
Chief Operating Officer & Director

Camille Sebaaly
Chief Financial Officer & Secretary

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

SBFM Stock - Frequently Asked Questions

How have SBFM shares performed in 2023?: Sunshine Biopharma's stock was trading at $0.64 at the beginning of 2023. Since then, SBFM stock has decreased by 4.7% and is now trading at $0.61.
View the best growth stocks for 2023 here.
Are investors shorting Sunshine Biopharma?: Sunshine Biopharma saw a increase in short interest in May. As of May 15th, there was short interest totaling 1,660,000 shares, an increase of 525.9% from the April 30th total of 265,200 shares. Based on an average daily trading volume, of 1,290,000 shares, the days-to-cover ratio is currently 1.3 days. Currently, 9.2% of the shares of the stock are sold short.
View Sunshine Biopharma's Short Interest.
When is Sunshine Biopharma's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 2nd 2023.
View our SBFM earnings forecast.
What is Sunshine Biopharma's stock symbol?: Sunshine Biopharma trades on the NASDAQ under the ticker symbol "SBFM."

How do I buy shares of Sunshine Biopharma?: Shares of SBFM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Sunshine Biopharma's stock price today?: One share of SBFM stock can currently be purchased for approximately $0.61.
How much money does Sunshine Biopharma make?: Sunshine Biopharma (NASDAQ:SBFM) has a market capitalization of $15.00 million and generates $4.35 million in revenue each year. The company earns $-26,740,000.00 in net income (profit) each year or ($1.69) on an earnings per share basis.
How can I contact Sunshine Biopharma?: The official website for the company is www.sunshinebiopharma.com. The company can be reached via phone at (514) 426-6161 or via email at investors@sunshinebiopharma.com.

This page (NASDAQ:SBFM) was last updated on 6/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial